These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3993331)
1. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ. Nagashima T; Hoshino T Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331 [TBL] [Abstract][Full Text] [Related]
2. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method]. Nagashima T; Hoshino T No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240 [TBL] [Abstract][Full Text] [Related]
3. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742 [TBL] [Abstract][Full Text] [Related]
5. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine]. Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301 [TBL] [Abstract][Full Text] [Related]
6. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA. Cheitlin RA; Bodell WJ Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750 [TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody]. Sasaki K; Murakami T; Takahashi M Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315 [TBL] [Abstract][Full Text] [Related]
8. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect. Ellwart J; Dörmer P Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine. Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629 [TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation. Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Vindelov et al. and bromodeoxyuridine/DNA double-staining flow cytometry methods for analysis of cell cycle distribution in rat thymocytes. Orfao A; Carbajo S; Dolbeare F; Ciudad J; Lopez A; Carbajo-Perez E Cytometry; 1996 Sep; 25(1):104-8. PubMed ID: 8875060 [TBL] [Abstract][Full Text] [Related]
12. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy. Gunduz N Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924 [TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma. Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726 [TBL] [Abstract][Full Text] [Related]
14. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody. Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235 [TBL] [Abstract][Full Text] [Related]
15. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data. Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804 [TBL] [Abstract][Full Text] [Related]
16. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine. Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082 [TBL] [Abstract][Full Text] [Related]
17. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370 [TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody]. Sasaki K; Murakami T; Ogino T; Takahashi M Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667 [TBL] [Abstract][Full Text] [Related]
19. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts. Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine. Nüsse M; Afzal SM; Carr B; Kavanau K Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]